Advertisement
The antiviral agent fluoxetine is well tolerated but is not effective for patients with proven or presumptive enterovirus D68-associated acute flaccid myelitis

No Efficacy Signal for Fluoxetine in EV-D68 Acute Flaccid Myelitis

0
Summative limb strength score decreased from initial examination to last follow-up with fluoxetine
The current Ebola outbreak in Congo is the worst in the country's recorded history

Ebola Outbreak Worst in Congo’s History

0
Deaths include 163 confirmed Ebola cases, 35 probable cases
Icosapent ethyl is associated with a reduced risk for ischemic events among patients with elevated triglyceride levels despite taking statins

AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides

0
Ischemic events reduced among patients with elevated triglycerides despite taking statins
When used perioperatively in elective abdominal aortic aneurysm repair

In Abdominal Aortic Aneurysm Repair, Curcumin Lacks Benefit

0
None of four biomarkers indicating injury or inflammation were significantly affected by curcumin
A fast

Quick New Ebola Test Approved by FDA

0
Administration authorizes emergency use of first Ebola fingerstick test with portable reader
Oral zoliflodacin

Zoliflodacin Seems Effective for Some Gonococcal Infections

0
In phase 2 trial, oral dose treats urogenital, rectal infections; lower efficacy for pharyngeal infections
The quantity of opioids prescribed after surgery is associated with patient-reported opioid consumption

Quantity of Opioids Prescribed Postop Linked to Consumption

0
Patients use 0.53 more pills for every additional opioid pill prescribed; pain also tied to consumption
A new version of an over-the-counter asthma inhaler that was taken off the market in 2011 has been approved by the U.S. Food and Drug Administration.

FDA Approves New Version of OTC Primatene Mist

0
Primatene Mist approved to provide temporary relief for symptoms of mild, intermittent asthma
A birth control coverage opt-out for employers was finalized by the Trump administration on Wednesday.

Trump Administration Finalizes Birth Control Coverage Opt-Out

0
Employers with religious objections will not have to provide no-cost birth control for female workers
For premenopausal women with stage I to IIIA estrogen receptor-negative

Improved Long-Term Pregnancy Outcomes for Goserelin + Chemo

0
Findings seen in premenopausal women with stage I to IIIA hormone receptor-negative breast cancer